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Obstruction of the rabbit ureter appears to alter the basic 
physiologic mechanisms governing beta-inhibitory adrenergic media¬ 
tion of ureteral smooth muscle relaxation. Obstructed ureters 
were relatively insensitive to isoproterenol in comparison to 
unobstructed controls. The potassium depolarized obstructed ureters 
developed a greater force of contraction than did the controls; 
however, the degree of contractility was not a factor in the in¬ 
sensitivity of obstructed ureters to isoproterenol. Theophylline, 
a phosphodiesterase inhibitor, caused a marked relaxation of both 
obstructed and unobstructed ureters. Furthermore, obstructed 
ureters which were contracted with a depolarizing concentration of 
potassium in the presence of theophylline were able to be relaxed 
when exposed to isoproterenol. 
Biochemical studies were in accord with the mechanical data. 
Basal adenylate cyclase activity of obstructed ureters was decreased 
and endogenous cAMP levels did not increase with administration 
of isoproterenol. Phosphodiesterase activity of obstructed ureters 
was less than that noted in the unobstructed controls. 
One possible explanation for these results is a possible 
defect in the beta-inhibitory receptor-adenylate cyclase link of 
obstructed ureteral smooth muscle. Alternatively, compartmentalization 
of phosphodiesterase in the obstructed ureters may allow sufficient 
levels of the enzyme to break down cAMP below a "threshold" level 




The question as to whether the autonomic nervous system 
has a role in control of ureteral function has been the subject 
of considerable debate. Recent studies have suggested that there 
are alpha stimulatory and beta inhibitory adrenergic receptors 
in the ureter. Isoproterenol, a beta-adrenergic agonist, has 
been shown to decrease ureteral contractility. Propranol, a beta 
blocker, has been shown to reverse the effect of isoproterenol. 
Beta-adrenergic induced relaxation of smooth muscle mv be 
mediated by cAMP (30, 31, 32). Weiss and associates (60) have 
demonstrated that rabbit ureters have beta adrenergic receptors 
and an adenylate cyclase-phosphodiesterase system. They showed 
that isoproterenol stimulated adenylate cyclase and that theophyl¬ 
line increased cAMP by inhibiting phosphodiesterase. Hausman 
et al. (6l) obstructed rabbit ureters and noted increases in 
ureteral contractility of the obstructed ureteral segments upon 
electrical stimulation. The observed increase in developed force 
was greater than that which would be by muscular hypertrophy 
alone. 
The present investigation was designed to examine the effects 
of acute obstruction on beta-inhibitory receptor stimulation 
of the ureter by isoproterenol. Specifically, changes in the 
relaxation characteristics of obstructed ureters in response to 
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beta-inhibitory receptor stimulation were correlated with adeny¬ 
late cyclase activity, phosphodiesterase activity and cAMP levels. 
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Adrenergic Influences on Ureteral Function 
The primary function of the mammalian ureter is to channel 
urine from the kidney into the bladder. This relatively simple 
task involves complex physiologic mechanisms which are still under 
considerable debate. Currently it is believed that electrically 
active pacemaker regions in the proximal portion of the upper 
urinary tract trigger action potentials. These electrical impulses 
are relayed distally via the intercellular conduction of the 
action potentials. The mechanical end result is a peristatic wave 
pattern which moves the bolus of urine toward the bladder. The 
uretero-vesical junction acts to prevent retrogra.de reflux and 
ensures antegrade urine flow. 
During intra-abdominal procedures, many surgeons have noted 
visible waves of ureteral peristalsis. The question arose "what 
controls these regular waves of ureteral contractions?" In 19^8 
there were proponents of a myogenic basis for the regulation of 
ureteral peristalsis. It was postulated that tonus and rhythmic 
contractions of the intact human ureter were independent of the 
nervous system. Furthermore, the major stimulus for initiation of 
a peristaltic wave was thought to be the urine flow from the 
kidney which stretched the smooth muscle fibers of the ureter. 
A pharmacologic evaluation of drugs which affect the central 
nervous system including the autonomic nervous system revealed 
7 

little direct effect on ureteral peristalsis (1). The only changes 
in ureteral function resulting from these agents were attributed 
to changes in urine flow. 
Further evidence in support of the myogenic theory was provided 
in a study which utilized an ureteroureteral anastomosis of a 
denervated dog kidney in a transplantation procedure. The dener¬ 
vation of the ureter did not interfere with the persistence of 
regular peristaltic activity (2). In another study, a segment 
from the midportion of the pig ureter was excised, its direction 
reversed and then reanastomosed without affecting pressure wave 
patterns, intraureteral pressure or kidney function. The per¬ 
sistence of antegrade peristalsis suggested that the propulsion of 
urine was entirely a myogenic function (3)• 
There is however increasing recent evidence that suggests 
that although the autonomic nervous system is not necessary for 
peristalsis, it may modify the character of ureteral peristalsis. 
Boyarsky et al. electrically stimulated the renal, nerves and 
observed an increase in ureteral peristalsis frequency (4). 
Furthermore, he stressed that the ureter had both alpha stimulatory 
and beta inhibitory adrenergic receptors which responded approp¬ 
riately to adrenaline, noradrenaline, isoproterenol and phenyl¬ 
ephrine. A high catecholamine content was also demonstrated in 
the ureter but the workers conceded they could not differentiate 
between vascular and muscular localization of these catecholamines 
(5). Other researchers have provided apparent histochemical 
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evidence of adrenergic and cholinergic fibers in close apposition 
to ureteral smooth muscle fibers (6). 
Longrigg et al. postulated that the response of smooth mus¬ 
cle preparations of human minor calycies to short duration electric¬ 
al stimuli, which were subthreshold for direct smooth muscle 
excitation, resulted from the liberation of noradrenaline. The 
catecholamines were thought to be released from postganglionic 
sympathetic nerves present within the ureteral tissue which sub¬ 
sequently combined with adrenergic receptors. Alpha blockade with 
phentolamine decreased the response to these short duration elec¬ 
trical impulses (7). Weiss observed that electrical stimuli that 
were subthreshold for direct muscle excitation also affected the 
contractile force generated by isolated segments of rabbit ureter 
by apparently exciting autonomic nerve endings within the ureteral 
tissue (8). 
Much of the confusion in the data regarding adrenergic in¬ 
fluences of the ureter has been derived from the varying techniques 
utilized by various investigators. Early in vivo techniques 
measured changes in urine flow rather than the ureteral peris¬ 
talsis (9). Later workers used indwelling pressure catheters 
which according to Dale et al. altered the regularity of peris¬ 
talsis (10). Despite the inconsistency of the data, there is, 
however, increasing evidence that there are indeed adrenergic 
receptors in the ureter. The role of these receptors in terms of 
the ultimate control of ureteral function is still to be defined. 
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Kaplan et al. investigated the effects of alpha and beta agonists 
on the in situ ureter. Although alpha receptor agonists increased 
in situ peristalsis, beta agonists had no consistent effect on 
tiie ureteral activity. They concluded that the effects were due 
to direct action of the agents on muscle cells and not via an 
indirect reflex mechanism involving the autonomic nervous system 
(11). Boatman et al. conducted a similar study and also con¬ 
cluded that the in situ ureter had alpha receptor activity without 
beta receptor response (12). On the other hand, McLeod and 
associates provided evidence that there were both alpha and beta- 
adrenergic receptors in the intact dog ureter (13). To ensure 
that the observed effects of antonomic agents on ureteral function 
were not due to changes in urine flow. Rose and Gillenwater 
perfused the in vivo canine ureter at a constant rate. They 
found that adrenergic agents (epinephrine and norepinephrine) 
increased the force of ureteral contractions and isoproterenol 
(a beta agonist) decreased ureteral contractility (1^). Tindall 
recognized the inadequacy of some of the previous investigations 
which disregarded the systemic physiologic effects of adrenergic 
agents which could falsely alter ureteral activity. He injected 
the spermatic artery and his results indicate that the rat ureter 
has alpha adrenergic activity at the distal end (15). Furthermore, 
Weiss and associates noted that the in vivo deformity of acutely 
obstructed rabbit ureters were greatly enhanced by reserpine 
which depleted catecholamines. They suggested that ureteral 
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tonus in an intact rabbit ureter was modified by adrenergic 
activity (16). 
The majority of workers have found that isoproterenol (beta 
agonist) inhibits in vivo ureteral peristalsis (13, 14, 15, 17) 
although here again some workers had not demonstrated a beta 
effect on the ureter (12, 11). In vitro studies on isolated ure¬ 
teral muscle strips have basically confirmed the in vivo evidence 
that isoproterenol reduced ureteral peristalsis (8, 18). 
Deane utilizing an isolated preparation of pig ureter demon¬ 
strated that alpha agonists increased motor activity whereas 
beta agonists decreased the motility. The effect of isoproterenol 
was blocked by propranalol (19). Weiss and associates studied 
the in vitro effect of adrenergic agents on ureteral segments. 
They demonstrated that electrical stimulation of ureteral muscle 
strips were augmented by alpha agonists and depressed by beta 
agonists (8). The norepinephrine induced increase in force of 
ureteral contractions was potentiated by propranalol and decreased 
by phentolamine. Malin et al. also demonstrated the presence of 
alpha stimulatory and beta inhibitory adrenergic receptors in human 
ureteral segments (18). 
The role of parasympathetic innervation of the in vivo ureter 
has not been defined. Most of the recent work has been contra¬ 
dictory and it is generally believed that parasympathetic innerva¬ 
tion has little effect on ureteral smooth muscle (14). 
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Basically the role of adrenergic innervation of the ureter 
can be characterized as one of modulation. It is conceded that 
the ureter may function without any adrenergic influence. The 
recent evidence, however, suggests that there are alpha-stimulatory 
and beta-inhibitory adrenergic receptors within the ureteral 
musculature and they may influence the character of ureteral 
motility. 
Cyclic Nucleotides and Smooth Muscle Function 
To understand the role of catecholamines on ureteral func¬ 
tion, the level of investigation must probe the basic physiologic 
mechanisms involved at the cellular level. During the decade 
that led to increased awareness of adrenergic involvement in 
ureteral peristalsis, researchers also were elucidating the role 
of cyclic nucleotides in cellular function. In what now is re¬ 
garded as one of the major breakthroughs in science during the 
last two decades, Sutherland, Rail and associates elucidated 
the enigma as to how epinephrine and glucagon were involved in 
the process of glycogenolysis in a whole liver preparation. They 
+P 
demonstrated that in the presence of ATP and Mg , epinephrine 
and glucagon activated phosphorylase in a cell-free system, a 
homogenate of rat liver (20). This activation of phosphorylase 
depended on the preliminary synthesis of a heat stable molecule, 
adenosine 3'» 5’ monophosphate, cyclic AMP which was formed 
when epinephrine and glucagon were added to the membrane containing 
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components of the whole homogenate (21). Additional work revealed 
that cyclic AMP was synthesized by an enzyme adenylate cyclase 
which is a structural component of the plasma membrane, which 
converted ATP to cyclic AMP in the presence of Mg+^ (22). Cyclic 
AMP was found to be rapidly inactivated by an enzyme —- phospho¬ 
diesterase which disrupts the phosphate-ribose ring to produce 
5"AMP (23). 
From this work, Sutherland and his associates formulated 
the second messenger concept. Basically, the first messenger is 
a hormone which travels from its own parent cell and is directed 
towards a target cell. In turn, once the first messenger reaches 
the target cell it combines with a specific receptor site on the 
outer membrane of the target cell. This initiates the formation 
of the second messenger, cyclic AMP, which evokes matabolic changes 
appropriate for the target cell in response to the hormonal 
stimulus (24). 
Specifically in the case of the ureteral smooth muscle 
an example of a first messenger is isoproterenol. This beta 
adrenergic agonist combines with the beta receptor site on the 
external aspect of the plasma membrane of a ureteral smooth muscle 
cell. Adenylate cyclase, which is spatially linked in close 
apposition to the beta receptor site is activated by the isopro¬ 
terenol beta receptor complex. Although isoproterenol does not 
directly enter the cell, its biologic effect is mediated via the 




synthesized in the presence of ATP and Mg probably leads to the 
activation of a protein kinase which is an important link in a 
complex cascade system which eventually leads to the uptake of 
Ca by the sarcoplasmic reticulum. The uptake of Ca into 
4-0 
storage areas decreases cytoplasmic Ca which then causes re¬ 
laxation of the smooth muscle. 
The specific evidence that cyclic nucleotides are directly 
involved in smooth muscle relaxation has not been clearly established. 
What exists are a series of investigations which seem to fit some 
of Sutherland’s criteria for cAMP media,tion of hormone action. 
These criteria include that: 1) the hormone should activate 
adenylate cyclase; 2) exogenous cAMP should mimic the effects 
of the hormone on the tissue; 3) the increase in cAMP which follows 
the application of a hormone should precede the functional events 
of the responding tissue; and 4) inhibition of phosphodiesterase 
should mimic or potentiate the functional response to the hormone 
(25). 
Effects of Adrenergic Drugs on Cell-free Preparations 
Sutherland and Rail in 1961 proposed that epinephrine induced 
relaxation of smooth muscle might be related to cAMP (26). This 
initial hypothesis failed to achieve experimental support when 
Klainer et al. showed that although epinephrine caused an increase 
in cAMP in a broken cell preparation of dog brain, it did not in¬ 
crease cAMP in dog aorta, femoral arteries, intestinal smooth 
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muscle and guinea pig ileum and taenia coli (27). However, in 1965, 
Butcher, Ho, Meng and Sutherland showed that epinephrine Increased 
cAMP in a broken cell preparation from the rat. Bueding et al. 
(1966) confirmed that physiologically active concentrations of 
epinephrine caused an increase in cAMP in a fractionalized homogen¬ 
ate of guinea pig taenia coli, a tissue that it also relaxed (29). 
With this evidence, the idea that smooth muscle relaxation, at least 
in some instances, was mediated by cyclic nucleotides gained consider¬ 
able attention. 
The Effect of Adrenergic Drugs on Whole Muscle Preparations 
Dobbs and Robison (1968) also postulated that beta adrenergic 
receptor stimulation resulted in uterine smooth muscle relaxation. 
Ihey noted that isoproterenol increased cAMP levels and relaxed 
isolated uterine smooth muscle strips. This effect was augmented 
by theophylline and by dibutyryl cAMP. Beta blocking agents inhibited 
the effect of isoproterenol although the effects of theophylline were 
unaffected (30). 
Andersson and Mohme-Lundholm (1970) studied the metabolic 
changes observed during relaxation of rabbit colon muscle by alpha 
and beta adrenergic agonists. Alpha-adrenergic stimulation was 
followed by a decrease in cAMP, phosphorylase a activity and hexo- 
sephosphates. Beta stimulation was followed by an increase in cAMP, 
hexosephosphates, and lactate and by a decrease in ATP. Beta block¬ 
ing agents inhibited these mechanical and metabolic effects induced 
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by beta-adrenergic agonists. The authors concluded that cAMP could 
possibly mediate beta-adrenergic induced relaxation of rabbit colon 
(31). 
Polacek and Daniel (1971) noted that adrenaline induced relax¬ 
ation of isolated rat uteri was associated with an increase in 
cAMP. These effects of epinephrine could be blocked by propranolol 
(beta blocker) but not by phenoxybenzamine (alpha blocker). This 
+? 
rise in cAMP occurred even in Ca free solution. Hat uteri pre¬ 
treated with propranolol contracted in response to alpha-adrenergic 
stimulation, an effect that was not associated with a change in 
cAMP. Uterine muscle strips pretreated with isoproterenol liad high 
cAMP levels, however, in spite of the increase in cAMP, oxytocin 
was still able to cause contractions. The authors concluded that the 
level of cAMP in the uterus was controlled by mechanisms related, 
to the beta receptors and not the alpha receptors (32). 
Verma and McNeil (1976) also noted that increases in cAMP 
of rat uterine segments occurred after stimulation with isoproter¬ 
enol, histamine and tyramine. The increase in cAMP observed with 
all three drugs was blocked by propranolol. The isoproterenol 
induced relaxation and the increase in cAMP was thought to be due to 
stimulation of beta-adrenergic receptors. After depletion of 
endogenous catecholamines with reserpine, histamine and tyramine 
were unable to elevate tissue cAMP levels. The authors concluded 
that the effect of those two drugs were mediated by the release of 
endogenous catecholamines (33). 
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An important paper by Andersson and Nilsson provided data to 
link smooth muscle relaxation with changes in cAMP and intracellular' 
calcium. They discovered a cAMP dependent Ca42 binding protein in 
the microsomal fraction and they were also able to show that there 
was a relationship between smooth muscle relaxation and an increase 
in cAMP content. ' The authors proposed that an increase uptake of 
calcium into intracellular storage sites and the resultant decrease 
in free cytoplasmic Ca+2 caused smooth muscle relaxation (3*0* 
This demonstration of a cAMP-dependent Ca+2 binding protein in 
the microsomal fraction is a key finding in linking changes in 
cAMP with smooth muscle relaxation, but it involved a tedious set 
of experiments and to date it has not been duplicated by other 
investigators. Tomiyama (1975) confirmed that there was a Ca+2 
binding microsoml fraction in guinea pig taenia coli, however, 
cAMP did not increase uptake of Ca+2 by the fraction. Tomiyama 
suggested that the failure of cyclic AMP to accelerate Ca+2 uptake 
could be due to the fact that there were several more unknown steps 
in between the increase in cAMP content and smooth muscle relaxa¬ 
tion (35) • 
The effects of angiotensin II and catecholamines on cAMP in 
rat aorta and tail artery were studied by Volicer and Hyme (1971)* 
Using labelled H3-AIP, catecholamines increased H3-AMP concentra¬ 
tions and this effect was blocked by propranolol. The authors 
could not explain the blocking effect of an alpha blocking agent on 
the catecholamine induced increases in cAMP content (JS). 
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Triner, Vulliemoz and Verosky (1972) were able to stimulate 
adenylate cyclase of rat aorta and relax the muscle strips using 
isoproterenol, epinephrine or norepinephrine in combination with 
phentolamine. Beta blocking agents antagonized the rise in cAMP and 
the relaxing effects of the catecholamines (37). Seidel (1975) 
using beef coronary arteries confirmed the findings of previous 
investigations that beta receptor stimulation resulted in vascular 
smooth muscle relaxation (38). 
Collins and Sutter (1975) were able to show that isoproterenol 
was unable to relax rabbit anterior mesenteric portal veins in a 
Na+-free solution despite increased levels in cAMP. They theorized 
that cAMP may be involved in isoproterenol induced relaxation 
possibly acting via increased Na-Ca^ exchange mechanisms (39). 
Recent work by Vulliemoz, Verosky and Triner demonstrated the effects 
of synthetic beta adrenergic stimulants on the cAMP system in smooth 
muscle. The agents albuterol and terbutaline raised cyclic AMP levels 
in rat uterus, aorta myocardium and dog bronchus and this effect was 
blocked by beta antagonists. Albuterol and terbutaline showed the 
greatest effect in the bronchus but less effect in the myocardium 
whereas isoproterenol elevated the levels of cAMP in all of the 
tissues. The authors concluded that the tissue specificity of 
albuterol and terbutaline may have an origin at the level of the 
cAMP system (AO). 
In studies on isolated venous tissue, Dunham et al. (197^) 
showed that prostaglandin E2 (PGE2) and isoproterenol were both 
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able to increase cAMP (4l). Vesin et al. (1974) however presented 
evidence that under certain conditions PGE^ could relax rat myometrium 
without increasing levels of cAMP. Catecholamine induced relaxation 
was associated with an increase ii cAMP in this tissue (42). Thus 
smooth muscle relaxation appears ii many instances to be related to 
increases in cAMP, although under certain circumstances cAMP independent 
mechanisms appear to be involved in relaxation of smooth muscle. 
Although tills review has provided evidence that catecholamines 
induce smooth rnuscle relaxation via beta adrenergic stimulation of 
adenylate cyclase, there are several more criteria set forth by 
Sutherland and associates that need to be fulfilled. Another cri¬ 
terion was that exogenous cAMP should mimic the effects of the 
hormone on the tissue. 
Effects of Exogenous cAMP 
Moore et a*1. (1968) demonstrated that dibutyryl cAMP (db cAMP) 
could produce prolonged relaxation of guinea pig tracheal smooth 
muscle. The relaxation induced by db cAMP could not be blocked by 
propranalol (beta blocker) (43). Dibutyryl cAMP is an analogue of 
cAMP which can be added exogenously and has the advantage of membrane 
permeability that exogenous cAMP does not have. In addition db 
cAlP inhibits phosphodiesterase and thus results in increases in 
intracellular cAMP. 
Dobbs and Robison (1968) utilizing uterine smooth muscle 
have provided data consistent with the fact that db cAlP and not 
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exogenous cAMP could mimic the effects of catecholamines and that these 
effects were potentiated by theophylline and not blocked by beta 
blocking agents (30). Triner, Overweg and Nahas (1970) noted epi¬ 
nephrine-like inhibitory actions of db cAMP (44). 
Bowman and Hall (1970) while studying the response of rabbit 
intestine to alpha and beta adrenergic stimulation noted the beta 
adrenergic-like effects of db cAMP (45). Andersson and Mohme- 
Lundholm (1970) compared the effects of exogenous cAMP and isopro¬ 
terenol. Although both compounds could relax intestinal smooth 
muscle, at low concentrations, exogenous cAMP could not activate 
phosphorylase (31). 
Takagi et al. (1971) studied the effects of db cAMP and con¬ 
cluded that the mechanism of action was related to membrane phenomena 
(46). Scmylo et al. (1970) showed that both dibutyryl cAMP and 
theophylline hyperpolarized the membrane of rabbit pulmonary arteries 
at low K+ concentrations and that this change in membrane potential 
was associated with relaxation (47). 
Pfaffman and McFarland (1973) studied the effects of theophyl¬ 
line and db cAMP on the phasic and tonic muscular contractions of 
guinea pig taenia coli. Theophylline and db cAMP both inhibited 
the phasic contractions while only theophylline inhibited the prolonged 
tonic contraction. The authors concluded that the basis for inhibi¬ 
tion of phasic contractures was related to mechanisms at the cellu¬ 
lar membrane level which may inhibit the inward Ca+^ movement re¬ 
quired for the production of the action potential (48). Ohkawa 
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(1975) also showed that db cAMP inhibited spike potentials and con¬ 
tractions of cat small intestine. This effect was not blocked by 
propranalol (49). Thus in many smooth muscles db cAMP appears to 
be able to cause relaxation and this effect is not inhibited by 
beta-adrenergic blocicing agents. 
Methylxanthines 
Another of the criteria of Sutherland and associates that 
is needed in order to implicate cAMP as a mediator of smooth muscle 
relaxation is that phosphodiesterase inhibitors should potentiate 
the relaxation of agents that induce relaxation via cAMP dependent 
mechanisms. Kukovetz and Poch (1970) illustrated that methylxan¬ 
thines inhibit phosphodiesterase in beef coronary arteries and this 
ability to inhibit phosphodiesterase activity was related to smooth 
muscle relaxation (50). 
Lugnier, Bertrand and Stoclet (1972) demonstrated a quantitative 
correlation between inhibition of phosphodiesterase activity and 
the prevention of rat aortic strip contractions induced by barium 
(51). Many other workers have confirmed the smooth muscle relaxant 
effects of the methylxanthines and its relationship with phosphodies¬ 
terase inhibition (38, 39, 52, 53, 54, 55). 
Current evidence basically supports the role of cyclic nucleo¬ 
tides in smooth muscle relaxation. There are several studies 
which argue against cyclic AMP mediation in relaxation. Schonhofer 
et al. were unable to stimulate adenylcyclase in a cell-free 
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preparation of vascular tissue (56). Vesin and Harbon, as previously 
mentioned, have demonstrated that prostaglandin Eunder certain 
conditions, was able to relax rat myometrium without raising cAMP 
levels (42). Furthermore, Namm et al. were unable to relax rabbit 
aortic strips with either db cAMP or cAMP (57). 
Furthermore, Polacek and Daniel (1971) did not observe any 
Increase in cAMP levels in rat uteri relaxed with low concentrations 
of papaverine, theophylline and diazoxide. ihey postulated that 
the methylxanthines tested did not bring about relaxation by phos¬ 
phodiesterase inhibition (58). 
Generally, the role of cyclic nucleotides on ureteral smooth 
muscle relaxation have yet to be extensively investigated. Potassium 
contracted ureteral segments may be relaxed by isoproterenol and theo¬ 
phylline (59). Weiss, in a recent study, stimulated adenylate cyclase 
activity in a cell-free preparation of rabbit ureter with isopro¬ 
terenol. He also was able to inhibit phosphodiesterase activity with 
theophylline. Hie rabbit ureter thus has adenylate cyclase activity 
which may be stimulated by beta-adrenergic agonists and phospho¬ 
diesterase activity which may be inhibited by theophylline. This 
serves as further evidence in favor of the presence of beta-adrenergic 
receptors in the rabbit -ureter. He showed that basal adenylate 
cyclase activity was lower in obstructed than in control's segments 
of rabbit ureter, although the percent increase in adenylate cyclase 
activity was greater in obstructed ureteral segments when isoprotere¬ 
nol was applied to obstructed and control segments (60). 
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In addition, recently Hausmari, Biancani and Weiss (6l) showed 
that segments of obstructed rabbit ureters developed a 3-fold greater 
contractile force than did control segments in response to electrical 
stimulation and that this was greater than that which would have 
been expected from muscle hypertrophy alone. From these data it 
would appear that basic changes probably occur at a cellular level 
in the obstructed ureter and in part these changes might be related 
to the cyclase-phosphodiesterase system. Therefore, this investi¬ 
gation was undertaken to study the differential effects of beta- 
adrenergic stimulation on obstructed and control ureteral segments. 
23 

MATERIALS AND METHODS 
White New Zealand female rabbits (2-3 kg) were anesthetized 
with sodium thiopental (30 mg/kg), intravenously. Ihrough a 5 cm 
midline suprapubic Incision the distal left ureter was identified 
and a 4-0 silk ligature was placed around the ureter and a parallel 
placed 16 gauge needle which was subsequently withdrawn to create 
a partial obstruction. The suprapubic incision was then closed. 
Two weeks after the onset of obstruction, the rabbits were 
re-anesthetized with intravenous urethane (1.6 g/kg) and both 
ureters were exposed through a midline transperitoneal incision. 
Platinum hooks were placed approximately 1 cm apart on the in situ 
obstructed and control ureter and secured with 4-0 silk ligatures. 
Exact measurement of the in vivo length of the selected ureteral 
segments was determined with a calibrated microscopic ocular which 
permitted determination of the distance between the hooks. While the 
measurements were being obtained, the ureters were kept moist by 
filling the abdominal cavity with tyrodes solution (137 nM NaCl; 
12 nM NaHC03; 1.8 mM Nat^PO^; 2.7 nM KC1; 2.7 rrM CaCl2; 0.5 irM 
MgCl2; 5.5 nM glucose). Tyrode solution was equilibrated with 95% 
C>2 and 5% C02, at 37° C. The segments were then excised and placed 
in a muscle chamber which was perfused with oxygenated lyrodes solu¬ 
tion. Chamber temperature was maintained at 37° C by flow of the 
tyrode solution through a glass coil heat exchanger that was heated 
by warm water from a constant temperature perfusion pump (Haake). 
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Hie warm water also circulated, through the water-jacket of the 
muscle chamber to help maintain a stable temperature. Temperature 
was monitored with a telethermometer and thermistor probe (Yellow 
Springs Instruments Co., Inc.). One end of the segment was affixed 
to a stationary platinum hook in the bottom of the chamber and the 
other end was attached to a Stathem UC-2 force transducer which 
was mounted on a moveable slide assembly which allowed for change 
in muscle length. Tension was monitored on a Grass polygraph 
(Model 7)• The muscle segment was stretched to apply a 500 mg tension 
and the new in vitro length was remeasured with a calibrated micros¬ 
copic ocular. After a 10 minute equilibration period a tonic 
contracture was achieved with a high potassium tyrode solution 
introduced into the muscle chamber (105 rrM KC1; 35 nM NaCl; 12 mM 
NaHCO^; 1.8 rrM NafhPO^; 2.7 rrM CaCl^; 0.5 irM MgClQ; 5.5 rrM dextrose). 
The high potassium tyrode solution was equiosmolar with the standard 
tyrode solution. The perfusion rate (70 ml/min) and temperature 
(37° C) were kept constant. After the level of the high potassium 
induced tension development became constant, appropriate concentrations 
of various agents were added to the high K+-tyrode solution and the 
magnitude of relaxation determined. 
Isoproterenol Dose-Response 
After obstructed and non-obstrusted ureteral segments were 
+ 
contracted with high K -tyrode solution and the tension development 
became stable, the perfusate was changed to high-K+ tyrode solution 
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containing 10-^ M isoproterenol. This solution was perfused for 15 
minutes and the magnitude of relaxation recorded. Normal tyrode 
solution was then reintroduced into the chamber and tension further 
declined to the resting level. The segments recontracted with high- 
K+-tyrode solution, relaxed with high K+-tyrode containing 10“8 m 
isoproterenol and then further relaxed to the resting level with 
tyrode solution containing a normal concentration of potassium. 
The cycle was then repeated with increasing concentrations of 
isoproterenol. The maximum concentration of isoproterenol employed 
was 10“6 M. 
Tieophylline Dose Response 
Obstructed and non-obstructed 'ureteral segments were contracted 
with high K -tyrode solution (105 nM KC1). After development of a 
stable contracture the perfusate was changed to high-K+ tyrode 
solution containing 10“9 M theophylline. After 15 minutes the 
perfusate was changed to high K+-tyrode containing 10"^ M theophylline. 
Increasing concentrations of theophylline were added during each 
subsequent 15 minutes interval until a maximum concentration of 10“^ 
M theophylline was delivered. The magnitude of the cumulative 
relaxation at each concentration was recorded. 
Isoproterenol Dose Response in Presence of Theophylline, 10~5 M 
Obstructed and non-obstructed ureteral segments were contracted 
with high K+-tyrode solution (105 nM KC1) containing theophylline, 
1 X 10“5 M. After development of a stable contracture isoproterenol 
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—Q + —5 
10 y M was added to the high K -tyrode containing 10 ^ theophylline. 
Increasing concentrations of isoproterenol were added during each 
subsequent 15 minute interval until a maximum concentration of 10“^ 
M isoproterenol was attained, ihe magnitude of the cumulative 
relaxation at each concentration was recorded. Normal tyrode solu¬ 
tion was then introduced, resulting in further relaxation to the 
resting level. 
_7 
Isoproterenol Dose Response in Presence of Phentolamine, 10 M 
Obstructed and non-obstructed ureteral segments were contracted 
with high K^-tyrode solution (105 mM KC1) containing phentolamine, 
-7 
1 X 10 ' M. After development of a stable contracture, increasing 
concentrations of isoproterenol were added to the perfusate at 
-9 
15 minute intervals, starting at 10 M isoproterenol until achieving 
a maximum concentration of 10"^ M isoproterenol. The magnitude of 
the cumulative relaxation at each concentration was recorded. Nor¬ 
mal tyrode solution was then introduced resulting in further relaxa¬ 




Figure 1 shows the relationship between potassium concentra¬ 
tion and force developed of unobstructed rabbit ureters. Optimum 
tension development occurred with 70 rrid potassium. A small decrease 
in force developed occurred at higher potassium concentration. The 
maximum force developed in response to tyrode solution containing 
70 rrM K*, was observed when a 500 mg resting tension was applied 
to the non-obstructed ureteral segnents (Fig. 2). 
Significant differences in percent relaxation were observed 
between obstructed and unobstructed rabbit ureters when exposed to 
isoproterenol. Obstructed ureters were insensitive to beta-adrenergic 
stimulation by isoproterenol, 10“9 M. This was contrasted by the 
considerable degree of relaxation which was noted with the unobstructed 
ureteral segments at the same isoproterenol concentration (0% obs¬ 
tructed vs. 52.8 + 8.27%* unobstructed) (P<.0025) (Table I). All 
data are expressed as the mean + the standard error of the mean (SEM). 
A similar differential sensitivity to the beta-adrenergic agonist 
was noted between obstructed and non-obstructed ureteral segnents with 
Q 
10 M isoproterenol (2.14 +_ 2.14% obstructed vs. 42.4 +7.0% unobs¬ 
tructed) (P<).0005). A further increase in the isoproterenol con¬ 
centration yielded a similar disparity in terns of percent relaxation 
between the obstructed and unobstructed ureteral segments. These 
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differences were 4.07 + 1.8l$ for the obstructed and 49.25 + 19.6$ 
for the unobstructed segments at 10“7 M isoproterenol (p<.025). 
Percent relaxation of the non-obstructed ureteral segments was not 
as great at 10“6 M isoproterenol (0$ obstructed vs. 14.0$ unobs¬ 
tructed) (p<.0005). 
The contractile force developed in response to the depolarizing 
concentration of potassium differed significantly between the obstructed 
and non-obstructed ureteral segments. In the sample that received 
10~9 m isoproterenol the mean contractile force developed of obstructed 
ureteral segments was 303.3 +80.89 mg as compared to 153-3 + 28.48 
mg for non-obstructed segments (.10<p<.05). Similar comparisons 
of the samples receiving other concentrations of isoproterenol were 
as follows: 10“6 m isoproterenol, 320 + 41.36 mg obstructed vs. 
150 + 30.4 mg unobstructed (p <.0025); 10“^ M isoproterenol, 281.5 
+ 68.58 mg obstructed vs. 98.75 + 43.89 mg unobstructed (p<.025); 
10-6 m isoproterenol, 311.25 + 36.95 mg obstructed vs. 77-5 +7.5 
mg unobstructed (p<.0005). 
To determine whether the differential sensitivity to isopro¬ 
terenol was due to the greater developed force of the obstructed 
ureteral segments, the data shown in Table I were re-analyzed using 
data only from those obstructed ureteral segments whose developed 
force in response to a depolarizing concentration of potassium 
was less than 300 mg (Table II). In the sample receiving 10“9 m 
isoproterenol the mean contractile force developed was 235 + 75 mg 
for obstructed segments vs. 153*3 + 28.48 mg for unobstructed 
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segments (p <.15). The difference in the degree of relaxation 
between the two groups was still significant. 0% relaxation was 
recorded for obstructed ureteral segments as compared to 52.8 + 
8.27% for unobstructed ureteral segnents (p<.005). The mean con- 
Q 
tractile force for segments subsequently receiving 10 ° M isoproterenol 
was 250 +19.32 mg for obstructed segnents vs. 150 + 30-40 mg for 
unobstructed segments (p<.01) and the degree of relaxation for the 
obstructed segments was .23 + .23% vs. 42.2 + 7.0% for the unobstruc¬ 
ted segnents (p <.0005). 
Similar results were obtained for segnents receiving lCT? M 
isoproterenol. The mean contractile force was 165 + 37.9 mg for the 
obstructed ureters vs. 98.75 +43.89 mg for the unobstructed ureters 
(p<.10). The percent relaxation was significantly different with 
2.78 + 1.79% relaxation for obstructed ureteral segnents as compared 
to 49.25 + 19-58% for the unobstructed segnents (p<.025). Mean 
contractile force for segnents subsequently treated with 10~6 M 
isoproterenol was 225.0 +32.27 mg for obstructed segnents vs. 77.5 
+ 7*50 mg for unobstructed ureters (p<.01). At this concentration 
of isoproterenol the percent relaxation of the obstructed ureters 
was 0% vs. 14 + 0 for the unobstructed ureteral segnents (p<.20). 
Thus the differential sensitivity to isoproterenol appears to persist 
even when comparing the percent relaxation of unobstructed ureteral 
segnents to obstructed segments which developed a lower and more 
comparable contractile force in response to high K+-tyrode. 
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The response to the cumulative addition of isoproterenol in the 
presence of an alpha-adrenergic blocker (lCT? Fhentolamine) is shown 
in Table III. Fhentolamine, 10“^ M did not affect the force of con¬ 
traction of obstructed and non-obstructed ureteral segments. A 
greater percent relaxation in response to isoproterenol was observed 
in non-obstructed than in obstructed ureteral segments in the presence 
of a low concentration of phentolamine (Fig. 1 and Table HI). Mean 
contractile force was 342.5 + 105.2 mg for the obstructed segments 
and 180 + 60 mg for the unobstructed segments. The percent relaxa¬ 
tion was as follows: 10“9 M isoproterenol - 0$ obstructed vs. 24.95 
+ 8.35$s unobstructed (p<.025); 10“^ M isoproterenol - 0.005 + 
0.0028$ obstructed vs. 33-3 + 0, unobstructed (p<.0005); 10”^ M 
isoproterenol - .005 + .0028$ obstructed vs. 48.8+12.5$ unobstructed 
(p<.0125); 10"6 M isoproterenol - .005 + .0078$ obstructed vs. 
29.15 + 29.14$ unobstructed (p<.15). 
The effect of a cumulative addition of theophylline to obstructed 
and non-obstructed ureters is shown in Fig. 4 and Table V. Both 
groups relaxed in response to theophylline, however at 10“^ M theophyl¬ 
line, the percent relaxation was significantly greater in the ncn- 
obstructed ureteral segments. The high K+-induced contractile 
force of segnents subsequently treated with theophylline was 743.33 
+ 152.46 mg for the obstructed segnents compared to 162.0 + 42.71 
mg for unobstructed segments (p<.005). The percent relaxation for 
both groups was as follows: 10“9 M theophylline, obstructed 1.75 
+ 1.75$; 10~8 m theophylline, obstructed 7*23 3.41$ vs. unobstructed 
5.92 +3.^2$ (p <.30); 10“7 M theophylline, obstructed 10.73 + 
5.28$ vs. unobstructed 17-96 + 9.46$ (p<.20); 10“6 M theophylline, 
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obstructed 13.0 + 6.68% vs. unobstructed 30.24 +15-43% (p<.10); 
10“6 M theophylline, obstructed 13*85 + 8.32% vs. unobstructed 
70.73 + 8.4l% (p<.0005); 10~;t M theophylline, obstructed 10.32 
+7.41%; 10"3 M theophylline, obstructed 19-93 + 6.67%. 
Comparison of the relaxing effects of thelphylline on unobstructed 
ureters and on obstructed ureters that did not contract more than 
450 mg in response to a depolarizing concentration of potassium 
revealed a similar relationship (Table VI). 
Data obtained when obstructed and unobstructed ureteral segments 
were initially contracted with high K+-tyrode solution and then 
immediately exposed to a 10 3 M concentration of theophylline, "ini¬ 
tial exposure group" are shown in Table VII. The results show that 
this group which was initially exposed to 10“3 M theophylline showed 
a greater percent relaxation than that of those exposed to a high 
concentration of theophylline only after a long period of time during 
which cumulative increasing concentrations of theophylline were 
delivered, "long exposure group" (Table V). The force developed 
in response to high K+-Tyrode solution for segments subsequently 
treated with an initial 10-3 M concentration of theophylline was 
229.1 + 36.58 mg for obstructed segnents vs. 152.5 + 33.0 mg for 
unobstructed segments (.10<p<.05) (Table VII). The percent relaxa¬ 
tion among this group exposed initially to 10~3 M theophylline was 
51 + 9-26% for obstructed segnents vs. 83.5 +2.90% for unobstructed 
segnents. A comparison between the "long exposure" and the "initial 
exposure" groups of obstructed ureters reveals that in terms of percent 
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relaxation the initial exposure group relaxed to a greater degree. 
The mean relaxation in response to 10“^ M theophylline for obstructed 
segments in the "long exposure group" was 19*90 + 6.66% vs. 51.0 
+ 9.26$ for obstructed segments in the "initial exposure group" 
(PC.025). 
The effect of 10-5 M theophylline on force developed in response 
to high K+-tyrode solution is shown in Table VIII. Obstructed and 
unobstructed ureters were contracted with a high Resolution containing 
10~5 M theophylline. Obstructed ureters exposed to high Resolution 
in the presence of 10“^ M theophylline contracted more than did 
obstructed ureters in the absence of theophylline. No significant 
difference was noted with unobstructed ureters contracted in the 
presence or absence of 10“^ M theophylline. Contractile force 
developed of obstructed ureteral segments in the presence of 10“^ M 
theophylline was 571.66 + 91.26 mg vs. 321.23 + 83-53 mg for obstructed 
segments in the absence of theophylline (p <.025). Contractile force 
-5 
developed of unobstructed ureters in the presence of 10 M theophyl¬ 
line was 116.66 + 3I.8 mg vs. 155-55 +_ 27.18 mg for the unobstructed 
segments in the absence of theophylline (p<.15). 
Obstructed ureters contracted with a high K+-solution containing 
10M theophylline were subsequently exposed to increasing cumulative 
concentrations of isoproterenol. Isoproterenol was able to relax 
ureters contracted in the presence of 10-5 m theophylline (Table IX). 
This was in contrast to the insensitivity to isoproterenol noted 
when obstructed, ureteral segments were contracted in the absence 




segments contracted and perfused in the presence of 10 M theophyl¬ 
line was as follow: 3.24 + 2.08$ with 10“^ M isoproterenol; 10.25 
+ 3.55% with 10“8 M isoproterenol; 23.98 + 4.39$ with 10""'7 M isopro¬ 
terenol; and 23.43 + 9-12% with 10”^ M isoproterenol. 
To aid in the interpretation of these data, prelirrdnary biochemical 
studies of the effect of obstruction on the cyclase-phosphodiesterase 
system of the ureter were initiated (Table X). Basal ureteral 
adenylate cyclase activity was lower in obstructed than in non- 
obstructed ureteral segments. A mean of 1,766 pmoles of cAMP were 
formed/rrg protein/5 minutes for obstructed ureteral segments as 
compared to 1,009 pmoles cAMP formed/mg protein/5 minutes for the 
non-obstructed ureters. Addition of NaF to the assay mixture resulted 
in an increase in adenylate cyclase activity; 2,99^.3 pmoles cAMP 
formed/mg protein/5 minutes for unobstructed segments and 2,024.8 
pmoles cAMP formed/mg protein/5 minutes for obstructed ureters. 
Isoproterenol, 10 ^ M, activated adenylate cyclase activity in 
obstructed and unobstructed ureteral segments. In unobstructed 
ureters, 2,016.5 pmoles cfflP were formed/mg protein/5 minutes whereas 
1,446 pmoles cAMP were formed/mg protein/5 minutes in obstructed ure¬ 
ters. This represented a 13-5$ increase above basal activity for 
unobstructed ureters vs. 43.3% increase above basal activity for 
obstructed ureters (Table X). 
In two experiments performed on pooled samples of ureters, basal 
endogenous cAMP levels were 17-32 and 18.91 pmoles/mg protein in 
unobstructed ureters and 22.50 and 30.24 pmoles/mg protein in 
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obstructed ureters. Incubation of the ureters in 2 X ICf^ M iso¬ 
proterenol for 90 sec resulted in an increase in cAMP in unobstructed 
ureters to 32.08 and 21.58 pmoles/mg protein whereas in obstructed 
ureters ciMP levels remained relatively unchanged at 23.08 and 15.27 
-2 
pmoles/irg protein. Theophylline, 10 M, caused an increase in cAMP 
levels of a pooled sample of unobstructed ureters form 18.91 to 86.24 
pnoles/mg protein and a moderate increase in cAMP in a pooled sample 
of obstructed ureters from 30.24 to 36.88 pmoles/mg protein. Theopbyl- 
-2 
line, 10 M, potentiated the increase in cAMP caused by isoproterenol. 
Endogenous cAMP levels were 49-38 and 83.33 pmoles/mg protein in 
obstructed and unobstructed ureters, respectively, that were incu- 
—6 0 
bated in 2 X 10 M isoproterenol and lO-^ M theophylline. After 
incubation In 10”^ M theophylline and 5 X 10"^ M isoproterenol the 
endogenous levels of cAMP were 72.50 and 119.89 pmoles/mg protein 
in obstructed and unobstructed ureters, respectively. 
Phosphodiesterase activity was less in obstructed than in 
unobstructed ureters. Figure 6 shows a Hofstee plot of the kinetics 
of cAMP-phosphodiesterase activity in obstructed and non-obstructed 
ureters. The Km’s were similar in obstructed and non-obstructed 





Hausman, Biancani and Weiss (6l) showed that ureteral obstruc¬ 
tion altered ureteral contractility. The magnitude of ureteral 
contractions in response to electrical stimulation was 250% greater 
in obstructed than in unobstructed ureters and this increase in 
active tension could not be explained by muscular hypertrophy, alone. 
Weiss and associates (60) also denDnstrated that the rabbit ureter 
has beta-adrenergic receptors and an adenylate cyclase-phosphodies¬ 
terase system. The present study was undertaken to examine the 
effect of obstruction on beta-adrenergic induced relaxation of the 
ureter and to correlate these effects with changes in the cyclase- 
phosphodiesterase system. 
The most significant finding of this study was the insensitivity 
of obstructed ureters to beta-adrenergic stimulation. Isoproterenol, 
10-9 to 1CT6 M had very little relaxant effect on obstructed ureteral 
segnents, although the same concentrations of isoproterenol were 
able to relax unobstructed ureters. 
A possible complicating factor in comparing the relaxant effects 
of isoproterenol on obstructed and unobstructed ureteral segnents 
was tbe significantly greater force developed of obstructed ureters 
in response to high K* solutions. This was in accord with the 
finding of Hausman et al. (6l), that obstructed rabbit ureters 
developed a greater force in response to electrical stimulation 
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than did unobstructed ureters. One can argue that this greater active 
force development by the obstructed ureters may have masked the 
relaxation induced by beta-adrenergic stimulation. Table II shows, 
however, that the differential sensitivity to isoproterenol was 
still evident when comparing beta-adrenergic induced relaxation of 
unobstructed ureters with relaxation of obstructed ureters that 
developed less than 300 mg of contractile force. With this method 
of sampling, force developed by obstructed and unobstructed ureters 
in response to a depolarizing concentration of potassium was not 
significantly different in ureters that were subsequently treated 
with 10“9 and 10“^ M, isoproterenol. Contractile force of obstructed 
-R -3 
ureters that subsequently were treated with 10 and 10 M iso¬ 
proterenol was still significantly greater than that of unobstructed 
ureters treated with equal concentrations of isoproterenol. Perhaps 
more comparable samples would have been achieved if a lower maximum 
contractile force of obstructed ureters had been used in Table II, 
but this would have limited too severely the number of segments 
available for comparison. In the future it might prove useful to 
compare relaxation of unobstructed ureters with that of obstructed 
ureters contracted with a lower concentration of potassium. This 
would hopefully further eliminate the inequalities of force developed 
by obstructed and unobstructed ureters and thus provide for more 
comparable samples for comparing the relaxing effects of isopro¬ 




Although isoproterenol is primarily a beta-adrenergic agonist, 
it does have some alpha-adrenergic stimulating activity (62). In 
order to eliminate the potential antagonistic effects of alpha- 
adrenergic stimulation on relaxation, an isoproterenol dose response 
curve in the presence of 10“^ M phentolanrme was used to evaluate 
"pure" beta-adrenergic responses of obstructed and unobstructed 
ureters. The results demonstrated that even with alpha-adrenergic 
blockade, isoproterenol could not relax obstructed ureters. Con¬ 
versely, the unobstructed ureters were relaxed by isoproterenol 
in the presence of 10~7 M phentolamine (Table III, Fig. 3)- 
That the obstructed ureter could be relaxed ms demonstrated by 
the finding that theophylline was able to relax the obstructed 
ureter (Table V, Fig. 4), although this relaxation was less than 
that observed with unobstructed ureters. The percent relaxation 
with the addition of 10”^ M theophylline was 51 + 9.26% for obstructed 
ureteral segments and 83-5 +2.9% for unobstructed ureters (Table VII). 
If isoproterenol induced relaxation of ureteral smooth muscle 
is related to an increase in cAMP, it would be possible that the 
insensitivity of obstructed ureters to beta-adrenergic stimulation 
inigjit be due to an increased phosphodiesterase activity in the 
tissue. Thus the effect of a cumulative addition of isoproterenol 
to obstructed ureters previously contracted in the presence of 
10“^ M theophylline, was studied. In the presence of 10"^ M theophyl¬ 
line, isoproterenol was able to cause relaxation of the obstructed 




ureteral segments was: 3*24 + 2.08% at 10 M isoproterenol; 
10.25 + 3.55% at 10“8 M isoproterenol; 23*98 + 1.39% at 10“ ? M 
isoproterenol; and 23.13 +9.12% at 10“^ M isoproterenol (Table IX, 
Fig. 5). This degree of relaxation was significantly greater than 
that resulting from the cumulative addition of isoproterenol to 
obstructed ureteral segments in the absence of theophylline (Table 
I). However, the percent relaxation resulting from the addition 
of isoproterenol to obstructed segments contracted and perfused 
in the presence of theophylline was significantly less than the 
relaxation resulting from the addition of isoproterenol to unobstructed 
ureteral segments (Table V). These latter experiments on unobstructed 
ureters were not done in the presence of theophylline, but such 
studies would only be expected to exaggerate the differences already 
observed. From these sets of experiments it would appear that the 
phosphodiesterase inhibitor, theophylline, may potentiate the 
relaxing effects of isoproterenol on obstructed ureteral segments; 
however, the relative insensitivity of obstructed ureteral segments 
to beta-adrenergic induced relaxation may be demonstrated whether 
or not the phosphodiesterase inhibitor is added to the perfusate. 
The relative insensitivity of obstructed ureteral segments to 
isoproterenol thus does not appear to be entirely due to an increased 
phosphodiesterase activity in the obstructed segments. 
Biochemical studies were thus undertaken in our laboratories 
by Weiss, Vulliemoz, Verosky and Triner to provide insight into 
the reasons for the mechanical evidence of a relative beta-adrenergic 
39 

receptor insensitivity of the obstructed 'ureters. In accord with 
the data obtained from the mechanical studies, basal adenylate 
cyclase activity was lower in obstructed ureters than in unobstruct¬ 
ed segments (1,009 pmoles cAMP/mg protein/5 min for obstructed 
vs. 1,776 pmoles cAMP/mg protein/5 min for unobstructed) (Table X). 
Even in the presence of NaF activation cf adenylate cyclase 
the unobstructed levels remained higher than the obstructed levels: 
2,994.8 pmoles cAMP/mg protein/5 min for unobstructed ureters vs. 
2,02*1.8 pmoles cAMP/mg protein/5 min for obstructed ureters. 
Isoproterenol 10-^ M stimulated adenylate cyclase activity. The 
mean amount of cAMP formed rose from 1,776 pmoles/mg protein/5 
min to 2,016.5 pmoles cAMP/mg protein/5 min in unobstructed ure¬ 
ters (13.5$ increase) and from 1,009 pmoles cAMP/mg protein/'5 min 
to 1,446 pmoles cAMP/mg protein/5 min in obstructed ureters (43•3% 
increase). Although NaE and Isoproterenol caused a larger percent 
increase in cyclase activity in obstructed than in unobstructed 
ureters, the total activity in these stimulated specimens was still 
lower in the obstructed ureters. 
The lower basal levels of adenylate cyclase activity in obs¬ 
tructed ureters and the lower total activity in obstructed ureters, 
even after beta-adrenergic stimulation, are in accord with the 
decrease percent relaxation resulting from isoproterenol applica¬ 
tion to obstructed ureters. Although these measures of total 
adenylate cyclase a.ctivity were lower in obstructed ureters, iso¬ 
proterenol caused a larger percent increase in adenylate cyclase 
activity above basal levels in the obstructed samples. Thus although 
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the obstructed ureter relaxes less in response to isoproterenol, 
it does possess adenylate cyclase activity which is responsive 
to beta-adrenergic stimulation. 
If isoproterenol induced relaxation of ureteral smooth muscle 
is mediated by cAMP, then an increase in endogenous cAMP might be 
observed in segments treated with isoproterenol. In addition, 
it was thought that obstructed ureters which have a lower adenylate 
cyclase activity and which are less sensitive to the relaxing 
effects of isoproterenol might demonstrate a smaller increase in 
cAMP after incubation with isoproterenol. 
Preliminary studies on several ureters seem to indicate that 
90 seconds of incubation with isoproterenol causes a moderate 
increase in cAMP levels in unobstructed ureters and has little 
effect on cAMP levels in obstructed ureters. These data correlate 
with the observed effects of isoproterenol on ureteral smooth 
muscle relaxation. Factors such as time of incubation in iso¬ 
proterenol and breakdown of cAMP by phosphodiesterase effect the 
measurements of these levels and further experiments will be 
required. In one preliminary study phosphodiesterase inhibition 
with theophylline potentiated the isoproterenol induced rise in 
cAMP in both obstructed and non-obstructed ureters. The endogenous 
cAMP levels, even under these conditions remained lower in the 
obstructed than in the unobstructed ureters. Thus these preliminary 
studies of changes in cAMP correlate well with the observed relaxing 
effects of these agents on the obstructed and unobstructed ureters. 

Studies of phosphodiesterase (PDE) activity of obstructed and 
non-obstructed ureters were undertaken to determine whether dif¬ 
ferences in PDE activity might account for the insensitivity of 
obstructed ureters to isoproterenol. Theophylline had increased 
the magnitude of the isoproterenol induced relaxation of obstructed 
ureters, although not to the degree noted with unobstructed ureters. 
An increased PDE activity in obstructed ureters might account for 
the lower cAMP levels in obstructed ureters after isoproterenol 
application and the lesser degrees of relaxation. However, this 
appears not to be the case since the obstructed ureter has a de¬ 
creased cAMP PDE activity in comparison to the non-obstructed 
ureter. Kinetic studies showed that the Km of both obstructed 
and unobstructed ureters were similar, but the of the unob¬ 
structed segments was greater. An increased PDE activity thus 
does not appear to be the cause of the decreased sensitivity of 
obstructed ureters to isoproterenol. 
The biochemical data supports the mechanical evidence that ob¬ 
structed ureters are less sensitive to isoproterenol than are unob¬ 
structed ureters. The major problem is in elucidating the defect 
in the relaxation process of the obstructed ureteral smooth muscle. 
It is possible that there is some defect in the beta-inhibitory 
receptor site on the obstructed ureter which accounts for the 
reduced ability of isoproterenol to stimulate adenylate cyclase 
and cause relaxation. Adenylate cyclase is in close apposition 
to the receptor site and the defect may also lie in the link between 

the receptor and adenylate cyclase. 
Since adenylate cyclase activity of obstructed ureters may 
be stimulated by isoproterenol and NaF, the receptor-adenylate 
cyclase system must be present in the obstructed ureters. The 
exact mechanism for the higher percent increase in activation of 
adenylate cyclase by these agents in obstructed ureters and the 
total decrease in activity in this tissue is not apparent. An 
increased phosphodiesterase activity is surely not accounting for 
the decreased sensitivity of obstructed ureters to isoproterenol 
_2 
induced relaxation. Although 10 M theophylline increased the 
ability of isoproterenol to relax the obstructed ureter, the percent 
relaxation was still less than that noted in the non-obstructed 
ureter. In addition, preliminary studies suggest the presence of 
a decrease in cAMP-PDE activity in obstructed ureters. This de¬ 
crease might be due to the fact that since the obstructed ureter 
has a decreased adenylate cyclase activity and less cAMP is formed 
in response to isoproterenol, a lesser amount of PDE activity 
is required to hydrolyze the available cAMP. Furthermore, it is 
conceivable, although probably unlikely, that compartmentalization 
of PDE in the obstructed ureter might lead to an increased activity 
in the vicinity of the cAMP, but yet a decreased overall activity. 
One could thus argue that compartmentalized pools of PDE are of 




It is possible that part of the beta-inhibitory adrenergic 
insensitivity of obstructed ureters may be due to a partial defect 
in the receptor-adenylate cyclase link. Therefore the obstructed 
ureters will have depressed tissue levels of cMP and the low 
phosphodiesterase enzyme activity, which might be compartmentalized, 
is still sufficient to break down cAMP below a "threshold" level 
that is required for relaxation. When high doses of isoproterenol 
were added in the presence of theophylline, sufficient cAMP might 
have been produced to promote relaxation. 
The decreased adenylate cyclase activity in obstructed ureters 
suggests that there is an intracellular biochemical defect accounting 
for the relative insensitivity of obstructed ureters to isopro¬ 
terenol-induced. relaxation. However, it must be kept in mind that 
the ultimate defect in the obstructed ureter may be at the level 
related to changes in the distribution of intracellular calcium. 
This work and the studies of Hausman et al (6l) show that in 
addition to the insensitivity to isoproterenol-induced relaxation, 
the obstructed ureter develops a greater force with electrical or 
high-K+ stimulation. Both the alteration in relaxation and in 
contraction may be due to alterations in calcium fluxes within the 
cell. It does not appear that a purely mechanical explanation can 
account for the insensitivity of obstructed ureters to beta-adrener¬ 
gic induced relaxation, since both obstructed and unobstructed 
ureters were relaxed to control resting tension when the perfusate 
was changed to a normal tyrode solution. 
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Additional studies are needed to further elucidate the beta- 
adrenergic insensitivity of the obstructed ureters. The effect 
of exogenous db cAMP would provide further evidence to meet Suther¬ 
land's criteria as to whether ureteral smooth muscle relaxation 
was mediated by cAMP. The relative sensitivity of obstructed and 
unobstructed ureters to db cAMP would help define the location 
of the defect in the relaxation process of obstructed ureteral 
smooth muscle. Hie efficacy of beta-adrenergic blockade with 
propranolol to alter the differential response to isoproterenol 
perhaps would aid in localizing the nature of the defect in obstructed 
ureters. Direct assay of beta receptors of obstructed ureters 
would be necessary to investigate any alteration of the receptor 
site. Furthermores studies of Ca++ fluxes in obstructed and unob¬ 
structed ureters might provide insight into whether differences 
++ 
in the sequestration of Ca by the sarcoplasmic reticulum might 
account for observed alterations in ureteral contraction and re¬ 
laxation . 
The results of this study indicate that there exist alterations 
in the basic physiologic mechanism governing smooth muscle relaxa¬ 
tion of obstructed ureteral muscle. Further experiments previously 
outlined would greatly enhance the elucidation of the mechanism 





Isuprel alone mg contraction mg relaxation % relaxation 
10 isuprel 
obst unobst obst unobst obst unobst 
n 3 3 3 3 3 3 
mean 3a 303.3 153-3 0 76.6 0 52.8 
SD 140.1 49.3 0 5.77 0 14.3 
SE +80.89 +28.48 0 +3.33 0 +8.27 
t (ob vs unob) 1.748 -23.0 -6.38 
P <.10 >.05 .0005 <.0025 >.0005 
_o 
10 Isuprel 
n 10 7 10 7 10 7 
mean xi 320 150 6 62.0 2.14 42.4 
SD 130 80.4 18.97 36.8 6.76 18,5 
SE +41.36 +30.4 +6.0 +13-9 +2.14 +7.00 
t (ob vs unob) 3.29 -3.75 “5.‘19 
P <.0025 >.0005 <.0025 >.0005 < . 0005 
_7 
10 Isuprel 
n 10 4 10 4 10 h 
mean xl 281.5 98.75 13.00 35-00 4.07 49.25 
SD 216.87 87.78 21.10 19.14 5.73 39.17 
SE +68.58 +43.89 +6.6 7 +9.57 +1.811 +19.58 
t (ob vs unob) 2.24 -1.88 -2. 30 
P <.025 >.01 <.05 >.025 <.025 >.0125 
10 ^ Isuprel 
n 8 2 8 2 8 2 
mean S3 311.25 77-5 0 10.00 .006 14.00 
SD 104.53 10.6 0 14.14 .006 0 
SE +36.95 +7-5 0 +10.00 .0001 0 
t (ob vs unob) 6.20 -1.00 7647 





 >.15 <.0005 

TABLE II 
Isuprel Dose Response 
Low Contractile Force Obstructeds 300 mg vs Total Population of 
Unobstrueteds 






10" '9 Isuprel IB 1C 
n 2 3 2 3 2 3 
mean wr 235 153.3 0 76.66 0 52.8 
SD 75 49.3 0 5.77 0 14.3 
SE 75 +28.48 0 +3.33 0 +8.27 
t 1.017 -23 .00 -6.38 
P <.20 >.15 < .0005 <.005 >.( D025 
10' 
0 
"° Isuprel 2B 2C 
n 6 7 6 7 6 7 
mean xn 250 150 10 62.0 .23 42.4 
SD ^7-33 80.4 22.36 36.8 .47 18.5 
SE 19.32 +30.40 10.00 +13.9 + .23 +7.00 
t 2.756 "3. 0B3 -6.03' 7 
P <.01 >.005 < .01 > .005 <.0005 
10' "7 Isuprel 3B 3C 
n 7 4 7 4 7 4 
mean xi 165 98.75 4.28 35.0 2.78 49.25 
SD 93 87.78 7.86 19.14 4.75 39.17 
SE +37-9 L43.89 +2.97 +9.57 +1.79 +19.58 
t l.l4l" -3. 06 -2.36 







1 <.025 > .0125 
10' "6 Isuprel 4B 4C 
n 4 2 4 2 4 2 
mean xt 225.0 77.50 0 10 0 14 
SD 64.54 10.60 0 14.14 0 0 
SE +32.27 +7.50 +0 +10 0 0 
t 4.451 -1. 00 -1.00 
P <.01 >.005 <.20 >.15 <.20 >.: 15 

TABLE III 
Isuprel Dose Response in the Presence of Phentolamine ~7M 
mg contraction % relaxation -9M 
obst unobst obst unobst 
n 4.0 2.0 4.0 2.0 
mean x^ 3^2.5 180.0 0 24.95 
SD 210.4 8.48 0 11.80 
SE +10.52 +6.00 0 +8.35 
t 1.34 -2.98 
P <.15 >.10 <.025 >.0125 
% relaxation -8M % relaxation -7M 
obst unobst obst unobst 
n 4 2 4.0 2.0 
mean .005 33.3 .005 45.8 
SD .005 0 .005 17.68 
SE .0028 +0 +.0028 +12.50 
t -3.66 
P < .0005 <.0125 >.01 
% relaxation -6M 
obst unobst 
n 4.0 2.0 
mean xj .005 29-15 
SD .005 41.23 
SE .0028 +29.14 
t -1.00 








































n 6 6 5 6 5 
mean X1 13.33 48.33 12.00 35.00 18,00 
SD 24.22 80.60 8.36 61.23 21.68 
SE +9.88 +32.90 +3.74 +25.00 +9.69 
t (ob vs unob) 1.097 .633 
P <.20 >.15 <.30 > .25 
-6m Theophylline -5M Theophylline -4m Theophylline 
Relaxation Relaxation Relaxation 
n 6 5 6 3 6 
mean 23.33 26.00 25.00 73.33 0 
SD 40.82 39.74 36.40 35.19 0 
SE +16.66 +17.77 +16.27 +20.27 0 
t (ob vs unob) 1.09 -1.89 

























Cumulative Theophylline Dose Response 
mg contraction 
Obst, Unobst 
n 6.0 5.0 
mean x7~ 743-33 162.00 
SD 1 373.45 95.50 
SE +152.46 +42.71 
t 3.67 
P <•005 >.1 






10 M Theophylline 10 Theophylline 
Obst Unobst Obst Unobst Obst Unobst 
n 6.0 6.0 5.0 6.0 5.0 
mean xT* 1.75 7.23 5.92 10.73 17.96 
SD 4.28 8.34 7.66 12.94 21.17 
SE +1.75 +3.41 +3.42 +5.28 +9.46 
t .272 -.667 









10_6M Theophylline 10 Theophylline 10 Theophylline 
n 6.0 5.0 6.00 3.00 6.00 
mean xl" 13.03 30.24 13.85 70.73 10.32 
SD " 16.37 34.50 20.38 14.57 18.16 
SE +6.68 +15.43 +8.32 +8.41 +7.41 
t -1.0234 ‘ -4.80“ 













Low Contraction Theophylline Dose Response % Relaxation - Cumulative 
mg contraction 
obst unobst 
n 3 5 
mean xt 450.0 162.0 
SD 226.05 95.50 
SE 130.51 42.71 
t 2.097 



















1 Theophylline 10 Theophyl. 
obst unobst obst unobst obst unobst 
3.0 3.0 5.0 3.00 5.00 
3-50 5.27 5.92 5.27 17.96 
6.06 7.05 7.65 9.12 21.14 
+3.50 +5.27 +3.42 5.26 +9.46 
-0.1040 -1.172 
<•9 <.2 : >.l 
10"Theophylline O
 1 
Theophylline 10“ Theophyl. 
3.0 5.0 3.0 3.00 3.00 
5.26 30.24 1.76 70.73 0 
9.12 34.49 3.06 14.57 0 
+5.26 15.43 +1.76 +8.41 0 
-1.531 -8.0214 
<.2 >.l <.001 
-3 






















































Comparison % relaxation between long exposure -3 vs 
initial exposure ~ obstructeds 
I relaxation long exposure - obst initial exposure - obst 
n 6.0 7.00 
mean x-. 19.90 51.0 
SD 16.32 24.5 







Effect of -5M Theophylline on Tonic Contraction 
mg contraction Obstructeds - KC1 without 
Theophylline 


















mg contraction Unobstructeds - KC1 without 
Theophylline 
























mean xl 571.66 
SD 223.55 
SE 91.26 
~9M Isoproterenol with -5M Theophylline (Obstructed Ureter) 
mg relaxation cumulative % relaxation 
n ~6700 ~67ocP 
mean xT 25.00 3.24 
SD 41.83 5.09 
SE +17.08 +2.08 
-8m Isoproterenol with -5M Theophylline (Obstructed Ureter) 
n 6.00 6.00 
mean xT 65.00 10.25 
SD 40.86 8.69 
SE +16.68 +3-55 
-7M Isoproterenol with -5M Theophylline (Obstructed Ureter) 
n 6.00 6.00 
mean xr 76.67 23.98 
SD 36.36 10.76 
SE +16.26 ±4.39 
-6M Isoproterenol with -5M Theophylline (Obstructed Ureter) 
n 6.00 6.00 
mean x=r 40.00 23.43 
SD 63.25 22.35 
SE +25.82 +9.12 

TABLE X 
Adenylate cyclase activity (P moles cAMP/mg protein/5 min) 
Controls 3 NaE % Inc. 10 ^ Isoproterenol % Inc 
unobstructed ave. 1,776 2,994.8 +68.6 2.0165 +13.5 
obstructed ave, 1,009 2,024 .8 +100.7 1.446 +43.3 
Endogenous cAMP (P moles/mg protein) 
unobstructed obstructed 
Control 17.32 18.91 20.49 22.50 30.24 24.93 
Isoproterenol 2 X 10“^M 32.08 21.58 23.08 15.27 
Isoproterenol 5 X 10~^M 26.82 28.24 21.65 20.97 27.53 
-5, 
Isoproterenol 1 X 10 iYI 16.79 19.44 22.16 18.69 
Control 18.91 30.24 
Theophylline 10 86.24 36.88 
Theophyl 10”^M + Isoprot. 2 x io_6m 83-33 49.38 
Theophyl 10“ + Isoprot. 5 X 10_6M 119.89 72.50 




Mean KC1 Dose Response Curve - Control Rabbit Ureters 
-1-j-4--I-—4-\-\- 




Control Rabbit Ureter - 70 nil KC1 
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